Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $5,457 - $6,422
25 Added 24.04%
129 $32,000
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $918 - $4,756
18 Added 20.93%
104 $23,000
Q1 2022

May 13, 2022

SELL
$243.64 - $270.48 $1,461 - $1,622
-6 Reduced 6.52%
86 $23,000
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $6,672 - $7,277
29 Added 46.03%
92 $23,000
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $14,621 - $16,183
63 New
63 $15,000
Q3 2020

Nov 18, 2020

SELL
$215.77 - $276.76 $16,614 - $21,310
-77 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$219.9 - $263.41 $13,853 - $16,594
63 Added 450.0%
77 $18,000
Q3 2019

Nov 12, 2019

SELL
$230.58 - $256.08 $922 - $1,024
-4 Reduced 22.22%
14 $4,000
Q2 2019

Aug 15, 2019

BUY
$217.4 - $246.08 $3,913 - $4,429
18 New
18 $5,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Stonebridge Capital Advisors LLC Portfolio

Follow Stonebridge Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.